Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd

Equities

600721

CNE000000KQ1

Biotechnology & Medical Research

End-of-day quote Shanghai S.E. 06:00:00 2024-04-29 pm EDT 5-day change 1st Jan Change
6.05 CNY +2.54% Intraday chart for Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd +6.14% -21.83%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Nanjing Huanglong Biotechnology Co., Ltd. announced that it expects to receive CNY 30 million in funding from Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd CI
Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Bai Hua Cun Pharma Tech Unit Raises Capital by 90 Million Yuan MT
Nanjing Huanglong Biotechnology Co., Ltd. announced that it expects to receive CNY 90 million in funding from Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd CI
Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Xinjiang Baihuacun Co., Ltd.(SHSE:600721) added to Shanghai Stock Exchange Composite Index CI
Xinjiang Baihuacun Co., Ltd.(SHSE:600721) added to Shanghai Stock Exchange A Share Index CI
Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Xinjiang Baihuacun Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Xinjiang Baihuacun Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Jiangsu Leeway Biological Technology Co., Ltd. announced that it expects to receive CNY 45 million in funding from Xinjiang Baihuacun Co., Ltd. CI
Xinjiang Baihuacun Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Xinjiang Baihuacun Co., Ltd. announced that it expects to receive CNY 338.746321 million in funding from Xinjiang Hualing International Medical Industry Development Co., Ltd CI
Xinjiang Baihuacun Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Xinjiang Baihuacun Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020 CI
Xinjiang Baihuacun Co., Ltd. cancelled the transaction announced on June 8, 2020 CI
Xinjiang Baihuacun Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020 CI
Xinjiang Baihuacun Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020 CI
Xinjiang Baihuacun Co., Ltd. Provides Earnings Guidance for the First Half of 2020 CI
Xinjiang Baihuacun Co., Ltd. announced that it expects to receive CNY 429.904 million in funding from Xinjiang Hualing International Medical Industry Development Co., Ltd CI
Chart Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd
More charts
Xinjiang Bai Hua Cun Pharma Tech Co Ltd is a China-based company principally engaged in pharmaceutical services. The Company's main business is the research and development, registration and application of small molecule chemicals and the development of peptide drugs. The Company is engaged in the early discovery and screening of new drugs, drug clinical trials, biological sample analysis, medicine testing services, active pharmaceutical ingredient (API) and intermediate supply. The Company is also engaged in leasing and property services. The Company mainly conducts business within the domestic market.
Calendar
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 600721 Stock
  4. News Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd
  5. Bai Hua Cun Pharma Tech Unit Raises Capital by 90 Million Yuan